The balance of financing receivables that were individually evaluated for impairment.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 11B
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=84173941&loc=SL6953423-111524

Name:	us-gaap_FinancingReceivableIndividuallyEvaluatedForImpairment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

FAIR VALUE MEASUREMENT AND DISCLOSURE (Narrative) (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financing Receivable, Individually Evaluated for Impairment	$ 4,355,000	$ 4,478,000	$ 6,264,000
Substandard [Member] \| Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financing Receivable, Individually Evaluated for Impairment	$ 500,000